DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

First Posted Date: 2004-04-12

Last Posted Date: 2011-03-28

Lead Sponsor: NYU Langone Health

Registration Number: NCT00004102

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-04-07

Last Posted Date: 2012-11-09

Lead Sponsor: NYU Langone Health

Registration Number: NCT00003132

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Phase 1

Completed

Conditions: Cancer

First Posted Date: 2004-02-20

Last Posted Date: 2011-03-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 20

Registration Number: NCT00003548

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract

Phase 2

Completed

Conditions: Endometrial Cancer
Sarcoma
Ovarian Cancer
Fallopian Tube Cancer

First Posted Date: 2004-02-09

Last Posted Date: 2016-03-11

Lead Sponsor: NYU Langone Health

Registration Number: NCT00003334

Locations: 🇺🇸
New York Presbyterian Hospital - Cornell Campus, New York, New York, United States
🇺🇸
Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States
🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

and more 2 locations

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2004-02-03

Last Posted Date: 2011-03-28

Lead Sponsor: NYU Langone Health

Registration Number: NCT00009997

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

The Research Registry for Neonatal Lupus

Completed

Conditions: Systemic Lupus Erythematosus
Neonatal Lupus
Sjogren's Syndrome
Congenital Heart Block

Interventions: Other: No intervention; observational

First Posted Date: 2003-12-12

Last Posted Date: 2023-08-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT00074373

Locations: 🇺🇸
Jill P. Buyon, MD, New York, New York, United States

SAM-e for the Treatment of Depression in Patients With Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease
Depression

Interventions: Drug: oral escitalopram
Drug: placebo
Drug: SAM-e

First Posted Date: 2003-10-13

Last Posted Date: 2016-07-13

Lead Sponsor: NYU Langone Health

Target Recruit Count: 29

Registration Number: NCT00070941

Locations: 🇺🇸
New York University, New York, New York, United States

Treatment for Women With Post-Traumatic Stress Disorder Related to Childhood Abuse

Not Applicable

Completed

Conditions: Stress Disorders, Post-Traumatic

Interventions: Behavioral: Psychotherapy treatment

First Posted Date: 2003-09-25

Last Posted Date: 2013-03-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 144

Registration Number: NCT00069381

Locations: 🇺🇸
NYU Child Study Center Institute for Trauma and Stress, New York, New York, United States

Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-09-04

Last Posted Date: 2011-03-28

Lead Sponsor: NYU Langone Health

Registration Number: NCT00010036

Locations: 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Early Prevention of Conduct Problems

Phase 4

Completed

Conditions: Conduct Disorder

Interventions: Behavioral: Family-Based Preventive Intervention

First Posted Date: 2003-06-04

Last Posted Date: 2013-07-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1050

Registration Number: NCT00051714

Locations: 🇺🇸
New York University Child Study Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy